2018 American Transplant Congress Archives - Page 42 of 211

A “Multi-Omic” Analysis of Proteome and Metabolome for Acute Rejection and PVAN in Kidney Transplantation

T. Sigdel, J. Yang, M. Sarwal.
A 3C Approach Drives Epigenetic Fixation of Foxp3 Expression and Stabilizes Treg Cell Lineage and Therapeutic Function

X. Xiao, X. Zhang, J. Li, S. Chen, P. Lan, Y. Dou, W. Chen, X. Li.
A 5-Tier System for Categorizing Program-Specific Adjusted Transplant and Waitlist Mortality Rate Ratios

A. Wey, N. Salkowski, B. Kasiski, A. Israni, J. Snyder.
A Calculated Panel Reactive Antibody (CPRA) Calculator Supporting Both Allele-Level and Antigen-Level HLA Specificities

L. Gragert,^1,2 E. Kransdorf,³ N. Kaur,¹ M. Maiers,² J. Kobashigawa,³ M. Pando.⁴
A Calculator for Kidney Transplant Waitlist Outcomes under the New Kidney Allocation System

A. Hart,^1,2 N. Salkowski,² A. Matas,³ B. Kasiske,² J. Snyder,² A. Israni.²
A Comparison of Alemtuzumab versus Antithymocyte Globulin Induction in High-Risk, Non-Sensitized Renal Transplant Recipients

S. Patel, A. Lichvar, E. Benedetti, P. West-Thielke.
A Comparison of the Discard Rate in Hepatitis C Deceased Liver Donors between Two Eras, 2008-2013 and 2014-2017. A Single Organ Procurement Organization Experience

M. Nazzal,¹ G. Marklin,² O. Okoye,¹ Y. Kim,¹ R. Ouseph.¹
A Cost Analysis on Normothermic Machine Perfusion at a Single Center

D. Pezzati, Q. Liu, H. Hassan, G. Iuppa, L. Hernandez, G. D'Amico, T. Diago Uso, B. Heghtsad, C. Miller, C. Quintini.
A Decade of Dual Kidney Transplantation Reveals Excellent Patient Outcomes from Otherwise Discarded Organs

I. Rajput, S. Farid, A. Hakeem, M. Jameel, N. Ahmad, O. Masood.
A Follow-Up Report on the Use of IVIG+Rituximab to Reduce Donor Specific Antibodies and Improve Transplant Rates in Highly-Sensitized Patients Awaiting Deceased Donor Kidney Transplantation

R. Najjar, E. Huang, A. Vo, J. Choi, K. Lim, S. Louie, A. Peng, S. Sethi, M. Toyoda, X. Zhang, S. Jordan.
A High Abdominal Aortic Calcification Score by Dual X-Ray Absorptiometry (DXA) is Associated with Cardiovascular Events after Kidney Transplantation

S. Benjamens,^1,2 R. A. Pol,¹ A. W. Glaudemans,² I. Wieringa,³ S. P. Berger,³ S. J. Bakker,³ R. H. Slart.²
A Long-Term Experience with Expansion of Milan Criteria for Liver Transplant Recipients

S. Commander,¹ B. Shaw,¹ L. Washburn,² D. Yoeli,² A. Rana,² J. Goss.²
A Low Level of De Novo DSA Sialylation is Associated with a Decreased of Allograft Survival in Non-Sensitized Kidney Transplant Recipients

M. Bonnet,^1,2 V. Pernin,^1,3 J-.E. Serre,¹ V. Georgescu,⁴ M. Le Quintrec,^1,2,3 G. Mourad,^1,2 J-.F. Eliaou,^2,5 C. Rene.^2,5
A Machine Learning Approach for Prediction of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients

S. Kawakita,¹ A. Waterman,^1,2 M. Everly.¹
A Medical Decision Analysis for the Use of Donation after Cardiac Death Donors for Simultaneous Liver-Kidney Transplant

A. Miller, K. Tennankore, B. Kiberd.
A Meta-Analysis for Induction Therapy of Kidney Transplantation: Comparison of Antithymocyte Globulin and Interleukin 2 Receptor Antagonist

G. Chen, Z. Wu, C. Wang, X. Liu, C. Wang, L. Chen.
A Mobile App to Improve Medication Adherence in Kidney Transplant Recipients – Analysis of a Prospective Interventional Study

F. Halleck, S. Georgi, D. Khadzhynov, D. Schmidt, E. Schrezenmeier, L. Lehner, P. Glander, K. Budde, O. Staeck.
A Multi-Center Analysis of Risk Factors for Pneumocystis Pneumonia (PCP) in Solid Organ Transplant Recipients

S. Hosseini-Moghaddam, M. Shokoohi, G. Singh, S. Dufresne, A. Jevnikar, D. Kabbani, H. Cardinal, I. Houde, M-.J. Hebert, A. Shoker, G. Prasad, A. Humar, D. Kumar.
A National Survey of Valganciclovir Dosing Strategies in Pediatric Solid Organ Transplant Recipients

S. Shaikh, N. Panek, J. Park.
A Natural Herb Danshen Suppresses Allospecific Memory CD8+ T Cell Generation and Murine Allograft Rejection

Z. Dai, H. Liu, Y. Chen, C-.L. Liang, F. Qiu.
A New Reality: Virtual Crossmatch Can Be Used Successfully as Pre-Transplant Compatibility Testing for Most Deceased Donor Transplants at a High Volume Center

R. Rajalingam,¹ D. Gae,¹ Z. Laszik,² G. Roll,³ M. Tavakol,³ C. Freise,³ D. Adey,⁴ A. Webber,⁴ D. Dobi,² K. Cunniffe,¹ G. da Gente,¹ N. Ascher,³ P. Stock,³ J. Roberts.³
A Novel Approach to Preserve Pancreatic Islet Grafts in Extrahepatic Space for Reversal of Diabetes Using Parathyroid Gland Co-Transplantation

C. Ward, G. Faleo, G. Nair, Q. Duh, M. Hebrok, W. Chang, P. Stock, Q. Tang.
A Novel Combined Formula to Direct Optimal Immunosuppressive Drug Exposure in Renal Transplant Recipients

O. Pankewycz,¹ E. Onan,² M. Laftavi,¹ R. Gruessner,³ H. Smileuski,¹ E. Alissandrello,¹ A. Gruessner.³
A Novel Conditioning Approach to Establish Chimerism Using Manipulation of JAK-STAT Pathways

H. Xu, A. Merchak, L. Kahn, A. Chhabra, Y. Wen, Y. Huang, S. Ildstad.
A Novel Dropout Risk Score in Hepatocellular Carcinoma (HCC) Patients Listed for Liver Transplant (LT) – Identifying a Threshold That Predicts Worse Post-LT Survival in Short Wait Regions

N. Mehta, J. Dodge, F. Yao.
A Novel Endothelial Cell Based Complement Dependent Cytotoxicity Test in Kidney Transplantation

R. Lammerts,¹ J. van den Born,¹ W. Dam,¹ M. Seelen,¹ B. Hepkema,² B. Kroesen,² M. Daha,¹ R. Pol,³ S. Berger,¹ On behalf of the COMBAT Consortium.¹
A Novel Nomogram-Based Approach for Defining the Effect of Transplantation on Cancer Recurrence Risk

N. Ejaz,¹ R. Alloway,¹ F. Paterno,¹ A. Singhal,¹ X. Ji,² M. Kattan,² E. Woodle.¹
A Novel Peripheral Blood mRNA Biomarker Predicts Subclinical Rejection and Kidney Transplant Outcomes

J. Friedewald,¹ S. Kurian,² T. Whisenant,² R. Heilman,³ E. Poggio,⁴ C. Marsh,² P. Baliga,⁵ N. Bridges,⁶ J. Odim,⁶ M. Brown,⁶ D. Ikle,⁷ B. Armstrong,⁷ J. Charette,¹ S. Brietigam,¹ N. Sustento-Reodica,¹ L. Zhao,¹ M. Kandpal,¹ D. Salomon,² M. Abecassis.¹
A Novel Preservation Solution for Lung That Improves Cell Viability and Tissue Architecture

J. Friedman,¹ M. Samamrco,¹ L. Marrero,¹ B. Bunnell,¹ D. Spyropoulos.²
A Novel Protocol to Improve Kidney Transplant Outcomes in Patients with Renal Disease Due to Amyloidosis

A. Langone, B. Concepcion, D. Slosky, R. Cornell, S. Horst, S. Goodman.
A Novel Score for Predicting Mortality and Graft Failure after Kidney Transplant

C. Parsons, F. Shamoun, S. Patel, S. Cha, R. Heilman, M. Keddis.
A Novel, Dose-Adjusted Tacrolimus Intrapatient Variability Model Identifies High-Risk Kidney Transplant Recipients Better Than Existing Methodologies

J. Kim, S. Wilson, Y. Song, J. Schwartz.
A Phase I/II, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients

S. Jordan,¹ J. Choi,¹ O. Aubert,² M. Haas,³ A. Loupy,² E. Huang,¹ A. Peng,¹ I. Kim,¹ S. Sethi,¹ S. Louie,¹ D. Puliyanda,¹ A. Vo.¹
A Phase-I Clinical Trial of Donor-Derived MIC Cell Infusion for the Induction of Donor-Specific Hyporesponsiveness after Living Donor Kidney Transplantation (TOL-1 Study)

C. Morath,¹ A. Schmitt,² C. Kleist,³ V. Daniel,³ G. Opelz,³ C. Süsal,³ F. Fälble,¹ C. Sommerer,¹ L. Wang,² M. Zeier,¹ M. Schmitt,² M. Schaier,¹ P. Terness.³
A Population Based Study of Incidence of Post Kidney Transplant Malignancies

D. Sexton,¹ J. O'Neill,² P. O'Kelly,¹ S. Murray,¹ S. Deady,³ E. O'Leary,³ P. Morris,⁴ P. Conlon.¹
A Pre-Transplant Blood-Based Lipid Signature for Prediction of Antibody-Mediated Rejection in Kidney Transplant Patients

G. Gupta, S. Bobba, D. Contaifer, P. Kimball, A. King, D. Kumar, M. Levy, J. Stern, D. Wijesinghe.
A Propensity Matched Survival Analysis: Do Simultaneous Liver-Lung Transplant Recipients Need a Liver?

K. Freischlag,¹ B. Ezekian,² P. Schroder,² M. Mulvihill,² S. Knechtle.²
A Proteomic Analysis of Kidneys Subjected to Normothermic Ex Vivo Kidney Perfusion (NEVKP) Demonstrates That Metabolism is an Important Determinant of Kidney Function Following Warm Ischemia

A. Konvalinka,^1,4 T. Tokar,² S. Reid,⁴ P. Urbanellis,⁴ M. Hamar,⁴ M. Kaths,⁴ I. Jurisica,² L. Robinson,^4,3 M. Selzner.^4,5
A Protocol for the Management of Alemtuzumab Induced Leukopenia in Kidney Transplant Recipients

S. Hammad, B. Ravichandran, M. Crist, B. Masters.
A Research-Informed Framework for a Medication Adherence Intervention to Support Transition of Adolescent Kidney Recipients to Independent Medication-Taking

T. Irizarry,¹ A. DeVito Dabbs,¹ M. Dew,¹ B. Foster.²
A Retrospective Review of De Novo Coccidioidomycosis among Remote Solid Organ Transplant Recipients in Arizona

T. Zangeneh,¹ J. August,¹ N. Beatty,¹ K. Asbury,² L. Mi,² J. Blair.²
A Review of Pediatric Drug Development Programs and FDA Labeling for Immunosuppressive Drugs in Organ Transplant Patients

G. Burckart,¹ M. Cavaillé-Coll,² A. Duong,³ L. Hothem,⁴ R. Albrecht.²
A Single Center Outcomes Analysis of UNOS Defined "Hard to Place Kidneys"

Y. Qazi, K. Lee, A. Jones, L. Aguirre, M. Parma, M. Smogorzewski, T. T. Maw, L. Sher.
A Single Center Transition of Care Model from Pediatric Heart Recipients to Adult Services Ongoing Study Model

S. Adams, M. Wigger.
A Six-Month, Prospective, Single-Center, Pilot Study to Determine the Pharmacokinetics and Effectiveness of Immunosuppressant Regimens in Liver Transplantation Patients Receiving Twice-Daily Tacrolimus and Everolimus (TAC + EVR BID) Regimen Converted to Once-Daily Tacrolimus and Everolimus (TAC + EVR QD) Regimen – A Priliminary Report

T-.H. Wu, C-.H. Cheng, Y-.C. Wang, C-.F. Lee, T-.J. Wu, H. Chou, K-.M. Chan, W-.C. Lee.
A Study to Identify Marginal Factors for Donors of Pancreas Transplantation in Japan

T. Ito, T. Kenmochi, K. Kurihara, N. Aida.
A Substantial Fraction of Surveillance Transplant Biopsies Have Clinically Actionable Findings

A. Shammout,¹ A. Naik,² M. Samaniego,² E. Farkash.¹
A Theoretical Framework to Explain Factors That Impact Completion of the Medical Evaluation Process for African American (AA) End-Stage Renal Disease (ESRD) Patient

C. Nonterah,¹ H. Gardiner,² D. Vavra.¹
A Transcriptomic Signature in PBMC from Kidney Transplant Recipients at Baseline Predicts Early Acute Rejection

W. Zhang,¹ Z. Yi,¹ P. Cravedi,¹ L. Li,¹ K. Keung,² C. Wei,¹ M. Menon,¹ J. Dudley,¹ P. O'Connell,² B. Murphy.¹
Ablation of Both mTOR and STAT3 in T Cells Induces Heart Transplant Acceptance in Donor Skin-Sensitized Mice

A. Xie,^1,2 W. Chen.^2,3
Ablation of IRF4 Induces Transplant Tolerance by Driving Intrinsic T Cell Dysfunction

J. Wu,^1,2 H. Zhang,¹ X. Shi,¹ X. Xiao,¹ Y. Fan,¹ J. Xia,² R. Sciammas,^1,3 X. Li,^1,3 W. Chen.^1,3
ABO Incompatible Deceased Donor Kidney Transplantation – Time to Remove the Barrier

J. Melancon,¹ M. Nayebpour,² K. Mahendran,¹ H. Spivak,¹ N. Koizumi.²
ABO Tolerance after Treatment of Infant or Adult Mice with MHC-Matched A-Expressing Blood Cells

B. Motyka,¹ J. Fersovich,¹ B. Lamarche,¹ M. Sosniuk,¹ I. Adam,¹ J. Pearcey,¹ K. Tao,¹ C. Cairo,² P. Cowan,³ L. West.¹
ABO-Incompatibility Lower Incidence of DSA-Induced Antibody-Mediated Rejection

D. Lee,¹ B. Kim,¹ J. KIm,¹ I. KIm,¹ M. Jeon.¹
ABO‐incompatible Deceased Donor Liver Transplantation

X. Luo, C. Haugen, A. Thomas, J. Garonzik-Wang, D. Segev.
Absence of Rejection in a Facial Allograft Recipient with a Postive Flow Crossmatch 24 Months after Induction with Rabbit Anti-Thymocyte Globulin and Anti-CD20+ Monoclonal Antibody

B. Gelb,¹ J. Diaz-Siso,² N. Plana,² A. Jacoby,² W. Rifkin,² K. Khouri,² D. Ceradini,² E. Rodriguez.²
Absolute Quantification of Plasma Graft-Derived Cell-Free DNA for Diagnosis of Kidney Transplant Rejection

J. Whitlam,¹ L. Ling,² F. Ierino,³ D. Bruno,² H. Slater,² D. Power.¹
Accepting a DCD Liver May Improve Patient Survival Compared to Waiting for a Non-DCD Liver

A. Wey,¹ N. Salkowski,¹ J. Lake,² W. Kim,³ B. Kasiske,¹ A. Israni,¹ J. Snyder.¹
Accommodation and Antibody Mediated Rejection Are Associated with Distinct TACI Polymorphisms in Kidney Transplant Recipients

M. Cascalho, M. Barbosa,¹ E. Farkash,² J. Platt.¹
ACEI/ARB Use within One Year of Kidney Transplant is Associated with Less AKI and Graft Loss in Older Recipients

M. Posadas Salas, R. Rodriguez, P. Amaechi, V. Rao, D. Taber.
Achieving Allograft Tolerance through Antigen-Specific Regulatory B Cells

C. Rickert,^1,2 S. Kimura,^1,2 L. Kojima,¹ K. Lee,¹ M. Aburawi,¹ F. Fontan,¹ K. Deng,¹ H. Yeh,^1,2 J. Markmann.^1,2
Acquired Resistance to Transplantation Tolerance as a Result of Prior Pregnancy Requires B Cells

A. Suah,¹ S. Khiew,¹ J. Young,¹ D. Yin,¹ Q. Wang,¹ M. Alegre,² A. Chong.¹
Activation Requirements of Costimulation Blockade-Resistant CD4 T Cells

J. Espinosa, B. Adams, J. Kearns, F. Shaw, R. Osborne, T. Woody, M. Ellis, J. Cheeseman, A. Kirk.
Activity Nanosensors for Early and Noninvasive Detection of Acute Organ Transplant Rejection

Q. Mac,¹ D. Mathews,² J. Kahla,¹ C. Stoffers,¹ O. Delmas,¹ B. Holt,¹ A. Adams,² G. Kwong.¹
Acute Antibody Mediated Rejection Treatment Impact on Class I and Class II Anti-HLA Antibodies in Pediatric Kidney Transplant Recipients

E. Kincaide,^1,2,3 K. Hitchman,^1,3 R. Hall,^1,2,3 I. Yamaguchi,³ B. Crowther.^1,2,3
Acute Murine CMV Infection Results in Loss of Intragraft CD73^HIFR4^HIPD1⁺ CD4 T Cells and Graft Rejection in Previously Tolerant Recipients

A. Dangi,¹ L. Zhang,¹ X. Zhang,² X. Luo.^1,2
Acute Tubular and Glomerular Kidney Injury Markers Reflect Ischemia-Reperfusion and Rejection

Y. Shim, R. Fan, N. Dvorina, W. Baldwin.
Addressing the “Crisis” in Pancreas Transplant Volume Using a Multidisciplinary Approach

J. Scalea, S. Bartlett, R. Barth.
Adjunctive Corticosteroid Immunosuppression Improves Hyperbilirubinemia Following Liver Transplantation (OLT)

G. Malat, D. Reich, G. Xiao, M. Harhay, K. Ranganna, D. Lee, S. Guy, S. Munoz.
Adjusted Body Weight Dosing of Rabbit Antithymocyte Globulin in Obese Renal Transplant Recipients Preserves Excellent Clinical Outcomes at 3 Years and Improves the Value of Care

J. Dann, A. Agarwal, M. Bradley, W. Ally.
ADL and IADL Limitations Resolve but New Cognitive Impairments Develop in Liver Transplant Recipients

J. Corriveau, R. Chandrasekhar, S. Geevarghese.
Adult-Sized Kidneys Transplanted into Infants and Small Children: Outcomes after Implementing Aggressive Fluid Regimen and Medications to Support Post-Transplant Perfusion

V. Sigurjonsdottir, P. Grimm, A. Chaudhuri.
Advanced Liver Care and Salvage Transplantation Improves Outcomes for Patients with Cirrhosis Requiring Abdominal General Surgical Procedures

D. Milgrom,¹ N. Valsangkar,¹ J. Kays,¹ T. Liang,¹ J. Butler,¹ C. Kubal,¹ M. Maluccio,¹ A. Tector,² L. Koniaris.¹
Advancement in Perioperative Outcomes of Living Donors in Pure Laparoscopic Right Hepatectomy

Y. Choi, H. Han, Y. Yoon, J. Cho, B. Lee.
After Action Review of Emergency Preparedness for “Hurricane Harvey” for LifeGift Houston

R. Wood, K. Myer.
Age Difference between Donor and Recipient Predisposes to Early Interstitial Fibrosis and Tubular Atrophy in Pediatric Kidney Transplantation

S. Panombualert, M. Pearl, P. Weng, R. Ettenger.
Age Stratified Efficacy and Safety Outcomes of Induction Immunosuppression in Renal Transplantation

D. McKimmy,¹ H. Kuzaro,² S. Sakya,³ K. Belfield,¹ E. Cohen.¹
Age-Specific Effects of Tacrolimus Are Associated to Specific Changes of T Cell Metabolism

Y. Nian, T. Heinbokel, K. Minami, R. Abdi, A. Elkhal, S. Tullius.
Aggressive Immunosuppression Minimization Shortens BK Viremia, Does Not Improve Outcome, but Increases the Risk of De Novo Donor Specific Antibodies in Kidney Recipients

A. Devresse,^1,2 C. Tinel,¹ A. Vermorel,¹ R. Snanoudj,¹ L. Morin,¹ V. Avettand-Fenoel,³ L. Amrouche,¹ A. Scemla,¹ J. Zuber,¹ C. Legendre,¹ M. Rabant,⁴ D. Anglicheau.¹
Aggressive Pursuit of Donation after Cardiac Death Kidney Donors with High Kidney Donor Profile Index: Good Use of Resources?

J. Rogge, C. Hostetler, B. Nicely, S. Rudich.
Air Pollution Can Support the Development of Cardiac Allograft Vasculopathy

C. Bara,¹ M. Barten,² D. Boethig,¹ Y. Scheibner,¹ J. Tauber,² H. Reichenspurner,² A. Haverich.¹
Alemtuzumab Induction as a Mediator of Nonadherence in Renal Transplantation

G. Mitro, O. Ekwenna, M. Rees, J. Ortiz.
Alemtuzumab Induction is Effective and Safe in Elderly Kidney Transplant Recipients

A. Toledo, K. Szempruch, P. Serrano, K. Andreoni, T. Kozlowski.
Alemtuzumab is Associated with Higher Rates of De Novo Donor Specific Antibody (DSA) in Patients with No Pre-Transplant DSA

N. Bath, S. Parajuli, G. Leverson, M. Jorgenson, J. Fose, T. Ellis, D. Kaufman, A. Djamali, R. Redfield.
All DQ DSA May Not Be Equal: Comparing Outcomes between De Novo DQ DSA Specificities

M. Everly,¹ K. Briley,² A. Nguyen,¹ V. Jucaud,¹ A. Maldonado,³ C. Haisch,² P. Bolin,² S. Kendrick,⁴ H. Jones,⁴ K. McLawhorn,⁴ D. Leeser,² L. Rebellato.²
Allogeneic Mesenchymal Stem Cells as Induction Therapy Are Safe and Feasible in Renal Allografts: Pilot Results of a Multicenter Randomized Controlled Trial

Q. Sun,¹ F. Han,¹ M. Zhao,² R. Cao,³ D. Zhao,¹ Z. Huang,¹ L. Hong,¹ Y. Peng,¹ Q. Sun.¹
Allogeneic T Follicular and T Conventional Responses Assessed by Proliferation, Cytokine Production, and TCR Clonality

C. Macedo,¹ M. Yamada,¹ X. Gu,¹ M. Suchoroski,² D. Hamm,² M. Kaplan,² D. Metes.¹
Allograft Function after 12 Months with Everolimus Plus Either Tacrolimus or Cyclosporine Compared to a Standard Regimen of Tacrolimus with MPA in De Novo Renal Transplant Recipients: The ATHENA Study

B. Nashan,¹ C. Sommerer,¹ B. Suwelack,¹ D. Dragun,¹ O. Witzke,¹ C. Hugo,¹ N. Kamar,² P. Merville,² A. Hauser,¹ P. Schenker,¹ M. Junge,³ F. Thaiss.¹
Alloreactive B Cells Acquire Cell-Intrinsic Hyporesponsiveness in Tolerant Recipients

S. Khiew,¹ D. Jain,¹ J. Young,¹ J. Chen,¹ J. Yang,¹ Q. Wang,¹ D. Yin,¹ R. Sciammas,² A. Chong.¹
Altered Function of Cytomegalovirus Specific T Cells in Transplant Recipients

L. Higdon,¹ J. Trofe-Clark,² S. Liu,¹ N. Saligrama,¹ K. Margulies,² M. Davis,¹ J. Maltzman.^1,3
Alveolar Macrophages Derived from MCMV Latently Infected Donors Drives the Viral Reactivation and Dissemination Following the Orthotopic Left Lung Transplantation in Mice

S. Han, Z. Zheng, M. He, J-.J. Wang, S. Yan, M. Abecassis, Z. Zhang.
AMD3100 (Plerixafor) as a Single-Dose Stem Cell Mobilizing Agent in Vascularized Composite Tissue Allograft (VCA) Transplantation in a Canine Model

B. Swearingen,^1,2 S. Graves,^2,3 R. Storb,^2,3 D. Mathes.^1,2
Amiodarone Use Increases Morbidity Not Mortality in Pediatric Heart Transplant Recipients

S. Amdani, A. Dalal, K. Simpson, J. Scheel, A. Abarbanell, P. Eghtesady, C. Canter, C. Castleberry.
An Early Look at the OPTN's New SLK Allocation Policy

A. Kucheryavaya,¹ R. Formica,² N. Turgeon,³ D. Stewart,¹ A. Wilk.¹
An Economic Analysis of the UK Pancreas Allocation Scheme

K. Burke,¹ S. Birch,^2,3 T. Augustine.¹
An Effective Tolerance Approach for Porcine Islet Xenotransplantation in Humanized Mice

F. Lee,¹ A. Dangi,¹ M. Burnette,¹ X. Zhang,¹ B. Hering,² X. Luo.¹
An Enhanced Educational Program for Kidney Transplant Candidates and Their Supports: Knowledge Gained but Room for Improvement

E. Clifton, A. Eshelman, D. Kim, A. Patel, P. Williams, D. Nicholson, K. Hogan, E. Rubinstein, D. Ramirez, N. Sadik, M. Jesse.
An In Vitro Model of Human Antibody-Mediated Rejection Depicts Key Role for NK Cells

L. Hidalgo,¹ M. Racape,² A. Loupy,² C. Lefaucheur.²
An Increase in Spot Urine Protein Excretion during the First Year after Kidney Transplantation Associates with Subclinical De-Novo Donor-Specific Antibodies and Microvascular Inflammation at 1-Year Surveillance Biopsies

M. Arnol,¹ G. Mlin[scaron]ek,¹ M. Oblak,¹ A. Kandus,¹ N. Kojc,² J. Buturović-Ponikvar.¹
An Individualized Strategy Using Virus and Immune-Based Markers to Prevent Cytomegalovirus Disease after Face Transplantation

R. Razonable, H. Amer, S. Mardini.
An Initial Experience with the Endowrist Robotic Endostapling Device for Renal Donor Nephrectomy

M. Tan, H. Pollinger.
An Integrative Approach for the Assessment of Peritubular Capillaritis Extent and Score in Microvascular Inflammation – Association with Transplant Glomerulopathy and Graft Loss

N. Kozakowski,¹ H. Herkner,² F. Eskandary,³ M. Eder,³ W. Winnicki,³ G. Bond,³ Ž. Kikić.³
An Open-Label Proof-of-Principle Phase 2a Study to Evaluate Autologous Hematopoietic Stem Cell Transplantation for Allogeneic Organ Transplant Tolerance (ASCOTT)

A. Chruscinski,¹ H. Atkins,² M. Macarthur,¹ C. Anne Marie,² D. Grant,¹ C. Bredsen,² E. Renner,¹ L. Lilly,¹ N. Selzner,¹ O. Adeyi,¹ R. Smith,¹ S. Moshkelgosha,¹ A. Humar,¹ S. Juvet,¹ G. Levy.¹
Analysis of Circulating CD38+/CD138+ Plasma Cells during Development of De Novo Donor Specific Antibody Responses

N-.N. Chai, G. Wu, I. Kim, S. Jordan, A. Klein.
Analysis of Cost Effectiveness of Treatment for Acute Antibody-Mediated Rejection

C. McDermott, K. Carsky, P. Ferrin, A. Gaines, D. Chernobylsky, M. Killackey, A. Paramesh, R. Zhang, J. Buell.
Analysis of Human Islet Damage during In Vitro Culture Using miRNA 375

Y. Shindo,¹ M. Levy,^1,2 M. Kanak.¹
Analysis of NIH Research Funding in Transplantation: The Important Impact of Physician-Scientists in Abdominal Transplant Research

A. Narahari, J. Mehaffey, A. Chandrabhatla, P. Baderdinni, L. Kron, K. Brayman.
Analysis of Patient Reported Outcomes for Patients That Received Living Donor Kidney Transplants

E. Venniro,^1,2 J. Taylor.^1,2
Analysis of Rabbit Anti-Thymocyte Globulin versus Basiliximab Induction in Pediatric Liver Transplant Recipients

D. Newland,¹ M. Royston,¹ D. McDonald,¹ K. Wallace-Boughter,² T. Németh,¹ K. Carlin,³ S. Horslen.²
Analyzing Geographic Disparity in the US Heart Allocation System

F. Karami,¹ M. Nayebpour,² M. Gentili,¹ N. Koizumi,² A. Rivard.³
Analyzing Transplant Medication Myths

R. Krislock, J. Brandenberger, P. Stracener, A. Weiss, K. Wipperling, C. Kuhr.
Angiotensin II Type 1 Receptor Antibodies as Markers of Post Transplant Focal Segmental Glomerulosclerosis and Proteinuria

A. Aala, M. Philogene, N. Alachkar.
Anti-Angiotensin II Type 1-Receptor Antibodies (AT1R-Ab) Induce a Specific Phenotype of Rejection Distinct from HLA Antibody-Mediated Rejection

C. Lefaucheur,¹ D. Viglietti,¹ O. Aubert,¹ A. Philippe,² P. Halloran,³ A. Loupy,¹ D. Dragun.²
Anti-IdeS Antibodies in IVIg and Its Effect on IdeS Activity

A. Runström,¹ S. Järnum,¹ S. Jordan,² L. Winstedt,¹ C. Kjellman.¹
Anti-Thymocyte Globulin Directly Binds and Functionally Inhibits Allo-Regulatory Myeloid Derived Suppressor Cells

Y. Lee, E. Davila, J. Bromberg, J. Scalea.
Anti-Thymocyte Globulin vs. Alemtuzumab: A Comparison of Long-Term Outcomes among Renal Transplant Recipients

E. Loncharic, A. Dodson, K. Gutierrez.
Anti-TIRC7 Antibody Acts Synergistically with Tacrolimus in Promoting Graft Survival in a Rat Kidney Transplant Model

S. Tullius,¹ Y. Kumamoto,² U. Nalan.³
Antibody Mediated Kidney Transplant Rejection Treated with Bortezomib – Case Series from a Single Center

G. Piecha,¹ R. Król,² H. Karkoszka,¹ A. Wiecek.¹
Antibody-Verified Eplet Mismatches as Determinants of Premature Kidney Transplant Loss

R. Sapir-Pichhadze,¹ X. Zhang,¹ A. Ferradji,¹ A. Madbouly,² S. Fingerson,² K. Tinckam,⁵ H. Gebel,³ H. Cardinal,⁴ B. Foster.¹
Anticoagulation in Pediatric Liver Transplantation; the Pros and Cons

M. Werner,¹ R. de Kleine,¹ M. de Boer,¹ V. de Meijer,¹ R. Scheenstra,² H-.J. Verkade,² F. Bodewes,² S. Bontemps,³ T. Lisman,¹ R. Porte.¹
Antihypertensive Medication Use after Kidney Transplant: Practice Variation and Clinical Outcomes

H. Yamout,^1,2 R. Ouseph,¹ M. Schnitzler,¹ H. Xiao,¹ V. Dharnidharka,³ A. Naik,⁴ N. Lam,⁵ F. Koraishy,^1,2 H. Randall,¹ D. Brennan,⁶ D. Segev,⁶ B. Kasiske,⁷ G. Hess,⁸ K. Lentine.¹
Antiproteinuric Effect of Spironolactone in Renal Transplantation: Effectiveness and Clinical Outcomes

M. Sousa, C. Do Valle, G. Rivelli, L. Camargo, R. Zollner, M. Mazzali.
Antiviral Therapy for Donor-Derived Hepatitis C Virus Infection after Solid Organ Transplantation

A. Kwong,¹ A. Wall,² M. Melcher,² U. Wang,³ A. Ahmed,¹ K. Khush,³ A. Subramanian,³ J. Tan,³ P. Kwo.¹
APOL1 Long-Term Kidney Transplantation Outcomes Network (APOLLO)

G. Guerra,¹ E. Poggio,² M. Ortigosa-Goggins,¹ M. Doshi,³ B. Freedman,⁴ D. Reboussin,⁴ P. Kimmel,⁵ APOLLO Investigators.
Apoptotic Exosome-Like Vesicles Induce Endothelial Cell Plasticity

F. Migneault,^1,2,4 M. Dieudé,^1,2,4 J. Turgeon,^1,4 D. Beillevaire,^1,2,4 M-.P. Hardy,^2,3,4 C. Perreault,^2,3,4 M-.J. Hébert.^1,2,4
Application of RNA-Seq Derived Diagnostic Algorithms of T-Cell Mediated Kidney Rejection (TCMR) to DNA Microarray-Based Gene Expression Datasets

Z. Wang,¹ L. Pan,² Z. Lyu,² P. Liu,³ G. Tseng,³ P. Randhawa.¹
Approaches to Prevention of Antibody Rebound after HLA Sensitization in a Mouse Model

I. Kim, G. Wu, N-.N. Chai, A. Klein, S. Jordan.
APRIL/BLyS Blockade Improves Depletion of Antibody Secreting B Cells Compared to BLyS Blockade Alone in Sensitized Murine Kidney Transplant Model

N. Bath,¹ X. Ding,¹ N. Wilson,² B. Verhoven,¹ A. Sukhwal,¹ L. Coons,¹ S. Panzer,² A. Djamali,² R. Redfield.¹
Aquaporin 4 Blockade Alters T Cell Trafficking through a Novel Mechanism of S1PR1 Regulation

M. Nicosia,¹ R. Fan,¹ S. Miyairi,¹ A. Beavers,¹ G. Farr,² P. McGuirk,² M. Pelletier,² A. Valujskikh.¹
Are Deceased Donor Characteristics Associated with Liver Graft Failure among Low MELD Patients Receiving a Liver Transplant Changing

K. Atiemo,¹ A. Skaro,² R. Craig-Schapiro,¹ S. Montag,¹ L. VanWagner,¹ M. Abecassis,¹ J. Levitsky,¹ L. Zhao,¹ D. Ladner.¹
Are Donation after Cardiac Death (DCD) Kidneys Unsuitable for Pediatric Recipients?

M. MacConmara,¹ S. Levea,² C. Hwang.¹
Artificial Graft Extension of Renal Vein in Living Kidney Transplantation

S. Cho,¹ W. Cho,¹ M-.J. Cho,¹ C. Choi,¹ S. Ahn,¹ S-.I. Min,¹ S-.K. Min,¹ S. Kim,² J. Ha.¹
As Clear as Mud: Volatility of the Five-Tier Quality Assessment of Kidney Transplant Centers in the United States

J. Schold,¹ K. Andreoni,² A. Chandraker,³ R. Gaston,⁴ J. Locke,⁴ A. Mathur,⁵ T. Pruett,⁶ A. Rana,⁷ L. Ratner,⁸ L. Buccini.¹
Assesment of a Novel Chronic Kidney Disease Educational and Goal Setting Tool among Liver Transplant Recipients

R. Leek,¹ J. Park,¹ C. Koerschner,² J. Mawby,³ J. Wright Nunes,⁴ C. Sonnenday,³ P. Sharma.²
Assessing Fibrosis Burden in Renal Allograft with Chronic Damage Using Functional Magnetic Resonance Imaging

J. Wen,¹ W. Wang,² X. Ni,¹ Y. Yu,³ J. Chen,¹ L. Zhang,³ Z. Liu.¹
Assessing Necroptosis in Brain Dead Kidney Donors: Implications for Predicting Recipient Outcomes

A. Zmijewska, J. Murphy, J. Chen, J. Zmijewski, R. Mannon.
Assessing Renal Transplant Candidate Survival at Listing Using a Risk-Adjusted Multi-State Semi-Markov Model

S. Mehrotra,¹ V. Kilambi.²
Assessing Response to Desensitization: What Makes Sense?

E. Kransdorf, J. Patel, M. Kittleson, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Assessing the Impact of Flow in Hypothermic Machine Perfusion on Human Venous Endothelium Using a Novel Ex Vivo Model

Y. Marie,¹ W. Ries,² K. Patel,¹ C. Turnbull,² N. Jamil,⁴ H. Caldwell,³ R. Telfer,² D. Neil,⁵ J. Nath,¹ N. Inston.¹
Assessment and Outcomes of Medication Nonadherence in Pediatric Kidney Transplant Recipients: Results from the IMPACT Study

A. Dokras,¹ M. Pearl,¹ J. Peipert,¹ P. Grimm,⁴ B. Warshaw,² E. Chambers,³ A. Kirk,³ R. Ettenger.¹
Assessment and Validation of Potential Predictors of Non-Adherence in Contemporary Kidney Transplant Recipients

T. Harrison, C. Perez, N. Patel, H. Meadows, J. Fleming, N. Pilch, B. O'Brien, H. Corbo, J. Hardcopf, P. Baliga, D. DuBay, D. Taber.
Assessment of a Discharge Transplant Knowledge Quiz and Its Impact on Outcomes in Liver Transplant Recipients

H. Corbo, N. Patel, N. Pilch, C. Perez, J. Fleming, T. Harrison, J. Hardcopf, H. Meadows, B. O'Brien, J. McGillicuddy, P. Baliga, D. Taber.
Assessment of Anti-CMV Immunity by Monitoring Anti-CMV Antibody (CMV-Ab) and CMV-Specific Cytotoxic T Cells (CMV-Tc) in Pediatric Kidney Transplant Recipients (Ped KTx Pts)

B. Shin,¹ H. Pizzo,² S. Jordan,² D. Lovato,¹ A. Petrosyan,¹ D. Puliyanda,² M. Toyoda.¹
Assessment of Anxiety, Fatigue and Depression in Pediatric Liver Transplant Recipients Using PROMIS Measures: A Pilot Study

S. Mohammad, M. Riordan, K. Neighbors, E. Alonso.
Assessment of Bile Production and Quality during Normothermic Ex Vivo Liver Perfusion to Predict Biliary Injury

D. Kollmann,¹ I. Linares,¹ S. Ganesh,¹ R. Rosales,¹ M. Hamar,¹ P. Urbanellis,¹ A. Wiebe,¹ P. Yip,² O. Adeyi,² M. Selzner,¹ N. Selzner.¹
Assessment of Donor Specific Anti-HLA Antibodies throughout SLK Transplantation

P. Jindra, M. Kueht, S. Gray, D. Giang, M. Cusick, A. Rana, B. Murthy, W. Etheridge, J. Goss, R. Kerman.
Assessment of Hepatic Ischemia-Reperfusion Injuries by NRF2-Dependent Transcriptional Activities of Bile Transporters in Rats

J. Kim,¹ A. Martin,¹ J. Yee,¹ L. Fojut,¹ A. Geurts,² K. Oshima,³ M. Zimmerman,¹ J. Hong.¹
Assessment of Immune Cell Profiles in HLA-Sensitized (HS) & Non-HS Patients (Pts) with End Stage Renal Disease (ESRD)

S. Ge,¹ M. Chu,¹ E. Ortiz,¹ A. Vo,² D. Lovato,¹ S. Jordan,² M. Toyoda.¹
Assessment of Methenamine Hippurate for the Prevention of Recurrent Urinary Tract Infections in Adult Renal Transplant Recipients: A Single Center, Retrospective Study

I. Hollyer,¹ F. Varias,³ B. Ho,¹ M. Ison.¹
Assessment of Peak Levels and Metabolism Rates in African American (AA) and Non-AA Kidney Transplant Recipients (KTR) on Immediate-Release Tacrolimus (IR-tac)

T. Horwedel,¹ R. Sodhi,² D. Tsapapas,³ M. Mills,⁴ S. Patel,⁴ G. Towns.⁵
Association between Donor/Recipient BK Viral Serostatus and Risk of BK Viraemia Post-Transplantation

S. Chong,¹ C. Atkinson,² N. Banga,¹ M. Harber,¹ M. Reeves,² C. Magee.¹
Association between Everolimus Trough Levels, Onset of Related Adverse Events, and Treatment Discontinuation after Liver Transplantation: 24-Month Results from the H2304 Study

J. Fung,¹ F. Saliba,¹ H. Schlitt,¹ G. Junge,² K. McCague,³ D. Patel,³ M. Charlton.¹
Association between Genetic Polymorphisms of Fc Gamma Receptor Genes (FcgR) and the Development of Donor Specific Antibodies (DSA) after Kidney Transplant

D. Min,¹ Y. Chang,² T. Shah.³
Association of Body Mass Index of Kidney Transplant Recipients with Graft Function Post-Transplant

A. Yaldo, I. Bajjoka, C. Crombez, M. Abouljoud.
Association of Health Literacy with Adverse Outcomes among Kidney Transplant Candidates and Recipients

F. Warsame, C. Haugen, J. Garonzik-Wang, N. Desai, D. Crews, T. Purnell, M. McAdams-DeMarco, D. Segev.
Association of Immunosuppressive Therapy Regimen with Sepsis Outcomes among Kidney Transplant Recipients

J. Donnelly,¹ P. MacLennan,¹ R. Mannon,¹ R. Saran,² J. Baddley,¹ H. Wang,³ G. McGwin, Jr.,¹ P. Muntner.¹
Association of Leptin with Cystatin C in Kidney Allograft Dysfunction

A. Bera,¹ M. Watson,² N. Gana,¹ J. Karaian,¹ S. Radhakrishnan,¹ M. Subramanian,¹ D. Little,² R. Nee,² A. Chatterjee,¹ S. Rothwell,¹ H. Pollard,¹ R. Jindal,³ M. Srivastava.¹
Association of Physical Function and Survival in Elderly Renal Transplant Recipients

A. Brar,¹ F. Tedla,¹ M. Salifu,¹ R. Gruessner,² D. John,² N. Sumrani,² A. Gruessner.¹
Association of Tacrolimus Adherence and Discontinuation with Sepsis Risk among Kidney Transplant Recipients

J. Donnelly,¹ P. MacLennan,¹ R. Mannon,¹ R. Saran,² J. Baddley,¹ H. Wang,³ G. McGwin, Jr.,¹ P. Muntner.¹
Association of CYP3A5*3*6*7 Metabolic Composites to Tacrolimus Pharmacokinetics in African American and Caucasian Renal Transplant Recipients

K. Tornatore,^1,5 D. Brazeau,² C. Meaney,¹ K. Attwood,^3,4 G. Wilding,⁴ S. Chang,⁵ R. Venuto.⁵
Associations among Physical Fitness/function, Pain and Depression in Kidney Transplant Patients

A. Kastelz,^1,2 I. Tzvetanov,¹ B. Fernhall,² A. Shetty,³ L. Gallon,³ G. Hachaj,⁴ E. Benedetti.¹
Associations of Poor Physical and Cognitive Performance and Kidney Transplant Waiting List Denial

M. Harhay,¹ K. Ranganna,¹ F. Michie,¹ C. Selinski,¹ T. Bajakian,¹ L. Levin Mizrahi,¹ J. Lee,¹ G. Malat,¹ G. Xiao,¹ D. Reich,¹ S. Guy,¹ P. Reese.²
AT1R Antibody Analysis: High Proportion of Non-Specific Reactivity?

A. Halpin,^1,3,4,5 S. Abou-Zeki,³ I. Larsen,^1,4 P. Campbell,^2,3,4,5 S. Urschel,^1,4,5 L. West.^1,3,4,5
Attitudes of African Canadian Patients with End Stage Kidney Disease toward Living Donor Kidney Transplantation

V. Gupta, C. Richardson, D. Belenko, N. Singh, A. Xu, P. Thiagalingam, D. Wong, H. Ford, M. Novak, I. Mucsi.
Autologous Adipose-Derived Stem Cells with In Vivo Immunomodulatory Properties Can Be Generated in Allograft Recipients under Immunosuppression

A. Sicard,¹ J. Rodriguez,² P. Petruzzo,³ J. Kanitakis,⁴ O. Damour,² L. Badet,⁵ A. Gazarian,⁶ F. Buron,¹ O. Thaunat,¹ K. Tarte,⁷ C. Mesnard,⁷ C. Auxenfans,² E. Morelon.¹
Automated Systems to Identify and Address Adherence Barriers Result in Sustained Reduction of Late Allograft Rejection

D. Hooper, C. Varnell, Jr., K. Rich, J. Huber, D. Dahale, A. Carle, A. Pai, A. Modi.
Autophagy Impacts Specificity and Characteristics of Innate Alloimmune Responses in Aging

T. Heinbokel, K. Minami, Y. Nian, A. Elkhal, S. Tullius.